Celltrion files IND for phase 3 trial of inhaled Covid-19 cocktail therapy
Celltrion Group (Celltrion Healthcare), a South Korean pharma company, has submitted an investigational new drug (IND) application to carry out a global phase 3 clinical ... Read More
Celltrion begins phase 1 human trial of COVID-19 antiviral antibody candidate
Celltrion Group, a South Korean pharma company, has launched a phase 1 human clinical trial of a potential antiviral antibody treatment for COVID-19 patients. The ... Read More